Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study
Janjigian, Y., Al-Batran, S., Wainberg, Z., Van Cutsem, E., Molena, D., Muro, K.,…Tabernero, J. (2024). Pathological complete response (pCR) to … Read More